Skip to content
Riskpilot
← Back to search
Sign in
Get full access
RECCURA THERAPEUTICS AS
AS
Active
Org 988071854
Dyre Halses Gate 3, 7042
Trondheim
Manufacture of basic pharmaceutical products
· NACE 2110
Est. 2005
2 employees
Watchlist
Share
Norway
/
Companies
/
Manufacture of basic pharmaceutical products
/
RECCURA THERAPEUTICS AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
1M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
-5M
2020
-18M
2021
-17M
2022
-6M
2023
-1M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
481
888
937
353
0
Staff expenses
−1 638
−1 104
−1 465
−818
−0
EBITDA
−5 009
−18 082
−17 294
−5 843
−1 467
Depreciation & amort.
−5 412
−9
−44
−153
−153
EBIT
−10 421
−18 091
−17 338
−5 996
−1 620
Net financials
34
1
−111
−116
55
Profit before tax
−10 387
−18 091
−17 449
−6 112
−1 565
Tax
−0
−0
−0
−0
−0
Net profit
−10 387
−18 091
−17 449
−6 112
−1 565
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
27 227
8 594
5 051
3 336
978
Equity
24 951
−5 780
2 171
−941
775
Long-term debt
0
0
0
0
0
Short-term debt
2 275
14 373
2 880
4 276
204
Total debt
2 275
14 373
2 880
4 276
204
Financial ratios
5-year trend
EBITDA margin
-146703700.0%
This company
15.8%
Market median
-928504530% vs market
2020
2024
Equity ratio
79.2%
This company
38.2%
Market median
+107% vs market
2020
2024
Return on equity
-202.1%
This company
18.4%
Market median
-1198% vs market
2020
2024
Net profit margin
-156492000.0%
This company
8.1%
Market median
-1932000100% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on RECCURA THERAPEUTICS AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
